Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Pulmonary Disease

被引:3
|
作者
Kim, Bo-Guen [1 ]
Kim, Sae Rom [2 ]
Jhun, Byung Woo [3 ]
机构
[1] Hanyang Univ, Coll Med, Dept Internal Med, Div Pulm Med & Allergy, Seoul, South Korea
[2] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Coll Med, Dept Pulm & Crit Care Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea
关键词
LUNG-DISEASE;
D O I
10.4046/trd.2023.0120
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:202 / 205
页数:4
相关论文
共 50 条
  • [41] Reduction in Hospitalizations Following Initiation of Amikacin Liposome Inhalation Suspension: A Retrospective Cohort Study of Patients in Real-World Settings
    Wu, J.
    Hassan, M.
    Cyhaniuk, A.
    Margiotta, C.
    Ratiu, A.
    Chatterjee, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [42] Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease
    Siegel, Sarah A. R.
    Griffith, David E.
    Philley, Julie V.
    Brown-Elliott, Barbara A.
    Brunton, Amanda E.
    Sullivan, Peter E.
    Fuss, Cristina
    Strnad, Luke
    Wallace Jr, Richard J.
    Winthrop, Kevin L.
    CHEST, 2023, 164 (04) : 846 - 859
  • [43] AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) ADDED TO COMBINATION REGIMEN ON RECURRENCE IN NEWLY DIAGNOSED OR RECURRENT MYCOBACTERIUM AVIUM COMPLEX (MAC): THE ARISE STUDY
    van Ingen, Jakko
    Terschlusen, Eva
    Yuen, Dayton
    May, Daniel
    Nevoret, Marie-Laure
    Ciesielska, Monika
    Stein, Daniel
    Mange, Kevin
    CHEST, 2024, 166 (04) : 995A - 996A
  • [44] THE RELATIONSHIP BETWEEN CULTURE CONVERSION AND IMPROVEMENT IN 6-MINUTE WALK TEST DISTANCE IN THE CONVERT STUDY EVALUATING AMIKACIN LIPOSOME INHALATION SUSPENSION FOR REFRACTORY MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE
    Mange, Kevin
    Roberts, Kevin
    Zandvliet, Anthe
    Witjes, Han
    Neve, Marta
    Lovern, Mark
    CHEST, 2019, 156 (04) : 1126A - 1126A
  • [45] The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults
    Khan, Omer
    Chaudary, Nauman
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2287 - 2294
  • [46] Phenotypic amikacin resistance may not indicate poor response to amikacin in Mycobacterium avium complex pulmonary disease
    Minuk, L. M.
    Brode, S. K.
    Mehrabi, M.
    Sharma, M. K.
    Stobart, M.
    Soualhine, H.
    Marras, T. K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (06)
  • [47] Amikacin Liposome Inhalation Solution (ALIS) for Treatment Refractory Pulmonary Mycobacterium Avium Complex; A Report of the First 50 Patients Who Have Received ALIS and Their Tolerance in a Tertiary Referral Center
    Kasperbauer, S. H.
    Levin, A. R.
    Huitt, G. A.
    Daley, C. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] In Vitro Amikacin Resistance Is Not Associated with In Vivo Outcomes in Patients with Mycobacterium Avium Complex Pulmonary Disease in Ontario, Canada
    Minuk, L.
    Brode, S. K.
    Mehrabi, M.
    Sharma, M.
    Soualhine, H.
    Marras, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
    Timothy Aksamit
    Jasmanda Wu
    Mariam Hassan
    Emily Achter
    Anjan Chatterjee
    BMC Pulmonary Medicine, 22
  • [50] Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
    Aksamit, Timothy
    Wu, Jasmanda
    Hassan, Mariam
    Achter, Emily
    Chatterjee, Anjan
    BMC PULMONARY MEDICINE, 2022, 22 (01)